시장보고서

상품코드

1511803

RNAi 기술 시장 규모, 점유율, 동향 분석 리포트 : 제품 및 서비스별, 용도별, 최종 용도별, 지역별, 부문별 예측(2024-2030년)

RNAi Technology Market Size, Share & Trends Analysis Report By Product & Services (Products, Services), By Application (Drug Discovery & Development, Functional Genomics), By End-use, By Region, And Segment Forecasts, 2024 - 2030

발행일: 2024년 06월 | 리서치사:

Grand View Research | 페이지 정보: 영문 120 Pages | 배송안내 : 2-10일 (영업일 기준)

샘플 요청 목록에 추가

※ 본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문 목차를 참고해주시기 바랍니다.

RNAi 기술 시장의 성장과 동향 :

Grand View Research, Inc.의 최신 리포트에 따르면 세계의 RNAi 기술 시장 규모는 2030년까지 66억 5,000만 달러에 달할 것으로 예측되며, 2024-2030년의 CAGR은 14.6%로 성장하고 있습니다.

기술의 발전과 신약 개발 및 약물 개발에 대한 적용 증가는 예측 기간 중 RNAi 기술에 대한 수요를 증가시킬 것으로 예상됩니다.

COVID-19 팬데믹은 시장에 긍정적인 영향을 미치고 있으며, COVID-19에 대한 효과적인 치료제와 백신 개발이 시급한 상황에서 RNAi를 포함한 RNA 기반 기술에 대한 자금 지원과 투자가 급증했습니다. 정부, 제약사, 바이오테크 기업은 RNAi 치료제의 개발 및 상용화를 가속화하기 위해 RNA 연구에 많은 투자를 하고 있습니다. 이로 인해 예측 기간 중 RNAi 기술에 대한 수요가 증가하고 있습니다.

또한 헬스케어에 대한 정부의 투자 확대는 예측 기간 중 시장 성장을 가속할 것으로 예상됩니다. 정부 및 관련 기관은 바이오의약품을 통한 치료를 장려함으로써 감염성 질환에 대한 의료비 지출을 최소화하기 위해 노력하고 있습니다. 국제적인 의료기관들은 다양한 질병에 대한 인식을 높이고 새로운 치료법을 발견하는 데 기여하고 있습니다. 새로운 치료법을 도입하기 위한 임상 연구에 대한 외부 자금 지원 증가는 제품 개발에 매우 중요합니다. 질병 부담을 줄이기 위한 약물전달 플랫폼 개발을 촉진하는 정부 주도의 노력은 시장 확대의 원동력이 되고 있습니다.

그러나 저개발국에서는 숙련된 전문가와 연구 지원이 크게 부족하여 역동적인 시장 진입에 큰 영향을 미치고 있습니다. 잘 훈련된 인력의 부족은 교육 격차와 지속적인 교육 기회의 부족으로 인해 더욱 악화되고 있습니다. 동시에 제한된 연구 자금, 인프라 부족, 복잡한 규제로 인해 이 지역의 과학 발전을 저해하는 요인으로 작용하고 있습니다. 이는 예측 기간 중 시장 성장을 저해하는 요인으로 작용할 것으로 예상됩니다.

RNAi 기술 시장 보고서 하이라이트

2023년 제품 및 서비스 시장은 제품 부문이 가장 높은 매출 점유율을 차지했습니다. 제품 부문은 miRNA, siRNA, 기타로 세분화됩니다. 이는 높은 제품 보급률과 키트&시약의 높은 사용률에 기인합니다. 반면, 서비스는 예측 기간 중 가장 빠른 속도로 성장할 것으로 예상됩니다.
용도별로는 신약 및 의약품 개발 분야가 2023년 68.87%의 가장 큰 시장 점유율을 차지하며 예측 기간 중 가장 빠른 속도로 성장할 것으로 예상됩니다. 이는 신약에 대한 수요 증가와 기술 발전의 확대에 기인합니다.
최종 용도를 기준으로 제약 및 생명공학 기업이 2023년 56.54%의 최대 매출 점유율로 이 부문을 지배했습니다. 반면 CRO&CMO는 예측 기간 중 가장 빠른 CAGR로 성장할 것으로 예상됩니다.
북미는 탄탄한 의료 인프라, 높은 첨단 의료 기술 도입률, 바이오의약품 연구개발에 대한 막대한 투자로 인해 2023년 38.54% 시장 점유율을 차지할 것으로 예상됩니다. 반면, 아시아태평양은 예측 기간 중 가장 높은 CAGR로 성장할 것으로 예상됩니다.

The global RNAi technology market size is anticipated to reach USD 6.65 billion by 2030 and is growing at a CAGR of 14.6% from 2024 to 2030, according to a new report by Grand View Research, Inc. The growing technological advancements and increasing applications in drug discovery and development are anticipated to increase the demand for RNAi technology over the forecast period.

The COVID-19 pandemic has had a positive impact on the market. The urgency to develop effective treatments and vaccines for COVID-19 led to a surge in funding and investments in RNA-based technologies, including RNAi. Governments, pharmaceutical companies, and biotech firms invested heavily in RNA research, accelerating the development and commercialization of RNAi therapies. This has increased the demand for RNAi technologies during the forecast period.

Moreover, growing government investments in healthcare are anticipated to fuel market growth over the forecast period. The government and relevant bodies are taking efforts to minimize healthcare expenditure on infectious diseases by promoting biopharmaceutical treatments. International healthcare institutions contribute to raising awareness and the discovery of new therapies for various disorders. Increasing external funding for clinical studies to introduce new drug treatments is pivotal for product development. Government-led initiatives to expedite the development of drug delivery platforms for reducing disease burden are driving market expansion.

However, undeveloped countries have a substantial shortage of skilled professionals and research support, profoundly impacting their participation in the dynamic market. The scarcity of a well-trained workforce is exacerbated by educational disparities and a lack of continuous training opportunities. Simultaneously, limited research funding, infrastructure shortcomings, and regulatory complexities impede scientific progress in these regions. This is anticipated to hamper the market's growth over the forecast period.

RNAi Technology Market Report Highlights:

The products segment dominated the product & services market with the highest revenue share in 2023. The product segment is further segmented into miRNA, siRNA, and others. This is attributed to the high product penetration and high usage of kits & reagents. On the other hand, services are expected to grow at the fastest rate over the forecast period
The drug discovery & development segment held the largest market share of 68.87% in 2023 for the application segment and is anticipated to grow at the fastest rate over the forecast period. This is attributed to the increasing demand for new drugs and growing technological advancements
Based on end-use, pharmaceutical & biotechnology companies dominated the segment with the largest revenue share of 56.54% in 2023. On the other hand, CROs & CMOs are anticipated to grow at the fastest CAGR over the forecast period
The North American region dominated the market share of 38.54% in 2023 due to its robust healthcare infrastructure, high adoption rates of advanced medical technologies, and significant investments in biopharmaceutical research and development. On the other hand, Asia Pacific anticipated growing at the highest CAGR over the forecast period

Chapter 1. Methodology and Scope

1.1. Market Segmentation and Scope
1.2. Market Definitions
- 1.2.1. Product & Service
- 1.2.2. Application
- 1.2.3. End-use
- 1.2.4. Region
1.3. Information analysis
1.4. Market formulation & data visualization
1.5. Data validation & publishing
1.6. Information Procurement
- 1.6.1. Primary Research
1.7. Information or Data Analysis
1.8. Market Formulation & Validation
1.9. Market Model
1.10. Objectives

Chapter 2. Executive Summary

2.1. Market Outlook
2.2. Segment Snapshot
2.3. Competitive Landscape Snapshot

Chapter 3. Market Variables, Trends, & Scope

3.1. Market Lineage Outlook
- 3.1.1. Parent Market Outlook
- 3.1.2. Related/Ancillary Market Outlook
3.2. Market Dynamics
- 3.2.1. Market Driver Analysis
  - 3.2.1.1. Increasing applications of RNAi technology in research and medicine
  - 3.2.1.2. Growing interest in personalized medicine
  - 3.2.1.3. Technological advancements in RNAi techniques
- 3.2.2. Market Restraint Analysis
  - 3.2.2.1. Lack of skilled professionals and research support in developing countries
3.3. Industry Analysis Tools
- 3.3.1. Porter's Five Forces Analysis
- 3.3.2. PESTEL Analysis
- 3.3.3. COVID-19 Impact Analysis

Chapter 4. RNAi Technology Market: Product & Service Business Analysis

4.1. Product & Service Segment Dashboard
4.2. Global RNAi Technology Market Product & Service Movement Analysis
4.3. Global RNAi Technology Market Size & Trend Analysis, by Product & Service, 2018 to 2030 (USD Million)
4.4. Products
- 4.4.1. Global Products Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 4.4.2. miRNA
  - 4.4.2.1. Global miRNA Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 4.4.3. siRNA
  - 4.4.3.1. Global siRNA Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 4.4.4. Others
  - 4.4.4.1. Global Others Market Estimates and Forecasts, 2018 - 2030 (USD Million)
4.5. Services
- 4.5.1. Global Services Market Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 5. RNAi Technology Market: Application Business Analysis

5.1. Application Segment Dashboard
5.2. Global RNAi Technology Market Application, Movement Analysis
5.3. Global RNAi Technology Market Size & Trend Analysis, by Application, 2018 to 2030 (USD Million)
5.4. Drug Discovery & Development
- 5.4.1. Global Drug Discovery & Development Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 5.4.2. Neurology
  - 5.4.2.1. Global Neurology Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 5.4.3. Oncology
  - 5.4.3.1. Global Oncology Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 5.4.4. Infectious Diseases
  - 5.4.4.1. Global Infectious Diseases Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 5.4.5. Metabolic Diseases
  - 5.4.5.1. Global Metabolic Diseases Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 5.4.6. Others
  - 5.4.6.1. Global Others Market Estimates and Forecasts, 2018 - 2030 (USD Million)
5.5. Functional Genomics
- 5.5.1. Global Functional Genomics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
5.6. Others
- 5.6.1. Global Others Market Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 6. RNAi Technology Market: End-use Business Analysis

6.1. End-use Segment Dashboard
6.2. Global RNAi Technology Market End-use Movement Analysis
6.3. Global RNAi Technology Market Size & Trend Analysis, by End-use, 2018 to 2030 (USD Million)
6.4. Pharmaceutical & Biotechnology Companies
- 6.4.1. Global Pharmaceutical & Biotechnology Companies Market Estimates and Forecasts, 2018 - 2030 (USD Million)
6.5. Academic & Research Institutes
- 6.5.1. Global Academic & Research Institutes Market Estimates and Forecasts, 2018 - 2030 (USD Million)
6.6. CROs & CMOs
- 6.6.1. Global CROs & CMOs Market Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 7. RNAi Technology Market: Regional Estimates & Trend Analysis by Product & Services, Application, End-use

7.1. Regional Dashboard
7.2. Market Size & Forecasts and Trend Analysis, 2018 to 2030
7.3. North America
- 7.3.1. North America RNAi Technology Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 7.3.2. U.S.
  - 7.3.2.1. Key Country Dynamics
  - 7.3.2.2. Competitive Scenario
  - 7.3.2.3. Regulatory Framework
  - 7.3.2.4. U.S. RNAi Technology Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 7.3.3. Canada
  - 7.3.3.1. Key Country Dynamics
  - 7.3.3.2. Competitive Scenario
  - 7.3.3.3. Regulatory Framework
  - 7.3.3.4. Canada RNAi Technology Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 7.3.4. Mexico
  - 7.3.4.1. Key Country Dynamics
  - 7.3.4.2. Competitive Scenario
  - 7.3.4.3. Regulatory Framework
  - 7.3.4.4. Mexico RNAi Technology Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.4. Europe
- 7.4.1. Europe RNAi Technology Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 7.4.2. UK
  - 7.4.2.1. Key Country Dynamics
  - 7.4.2.2. Competitive Scenario
  - 7.4.2.3. Regulatory Framework
  - 7.4.2.4. UK RNAi Technology Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 7.4.3. Germany
  - 7.4.3.1. Key Country Dynamics
  - 7.4.3.2. Competitive Scenario
  - 7.4.3.3. Regulatory Framework
  - 7.4.3.4. Germany RNAi Technology Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 7.4.4. France
  - 7.4.4.1. Key Country Dynamics
  - 7.4.4.2. Competitive Scenario
  - 7.4.4.3. Regulatory Framework
  - 7.4.4.4. France RNAi Technology Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 7.4.5. Italy
  - 7.4.5.1. Key Country Dynamics
  - 7.4.5.2. Competitive Scenario
  - 7.4.5.3. Regulatory Framework
  - 7.4.5.4. Italy RNAi Technology Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 7.4.6. Spain
  - 7.4.6.1. Key Country Dynamics
  - 7.4.6.2. Competitive Scenario
  - 7.4.6.3. Regulatory Framework
  - 7.4.6.4. Spain RNAi Technology Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 7.4.7. Denmark
  - 7.4.7.1. Key Country Dynamics
  - 7.4.7.2. Competitive Scenario
  - 7.4.7.3. Regulatory Framework
  - 7.4.7.4. Denmark RNAi Technology Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 7.4.8. Sweden
  - 7.4.8.1. Key Country Dynamics
  - 7.4.8.2. Competitive Scenario
  - 7.4.8.3. Regulatory Framework
  - 7.4.8.4. Sweden RNAi Technology Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 7.4.9. Norway
  - 7.4.9.1. Key Country Dynamics
  - 7.4.9.2. Competitive Scenario
  - 7.4.9.3. Regulatory Framework
  - 7.4.9.4. Norway RNAi Technology Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.5. Asia Pacific
- 7.5.1. Asia Pacific RNAi Technology Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 7.5.2. Japan
  - 7.5.2.1. Key Country Dynamics
  - 7.5.2.2. Competitive Scenario
  - 7.5.2.3. Regulatory Framework
  - 7.5.2.4. Japan RNAi Technology Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 7.5.3. China
  - 7.5.3.1. Key Country Dynamics
  - 7.5.3.2. Competitive Scenario
  - 7.5.3.3. Regulatory Framework
  - 7.5.3.4. China RNAi Technology Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 7.5.4. India
  - 7.5.4.1. Key Country Dynamics
  - 7.5.4.2. Competitive Scenario
  - 7.5.4.3. Regulatory Framework
  - 7.5.4.4. India RNAi Technology Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 7.5.5. Australia
  - 7.5.5.1. Key Country Dynamics
  - 7.5.5.2. Competitive Scenario
  - 7.5.5.3. Regulatory Framework
  - 7.5.5.4. Australia RNAi Technology Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 7.5.6. Thailand
  - 7.5.6.1. Key Country Dynamics
  - 7.5.6.2. Competitive Scenario
  - 7.5.6.3. Regulatory Framework
  - 7.5.6.4. Thailand RNAi Technology Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 7.5.7. South Korea
  - 7.5.7.1. Key Country Dynamics
  - 7.5.7.2. Competitive Scenario
  - 7.5.7.3. Regulatory Framework
  - 7.5.7.4. South Korea RNAi Technology Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.6. Latin America
- 7.6.1. Latin America RNAi Technology Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 7.6.2. Brazil
  - 7.6.2.1. Key Country Dynamics
  - 7.6.2.2. Competitive Scenario
  - 7.6.2.3. Regulatory Framework
  - 7.6.2.4. Brazil RNAi Technology Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 7.6.3. Argentina
  - 7.6.3.1. Key Country Dynamics
  - 7.6.3.2. Competitive Scenario
  - 7.6.3.3. Regulatory Framework
  - 7.6.3.4. Argentina RNAi Technology Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.7. MEA
- 7.7.1. MEA RNAi Technology Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 7.7.2. South Africa
  - 7.7.2.1. Key Country Dynamics
  - 7.7.2.2. Competitive Scenario
  - 7.7.2.3. Regulatory Framework
  - 7.7.2.4. South Africa RNAi Technology Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 7.7.3. Saudi Arabia
  - 7.7.3.1. Key Country Dynamics
  - 7.7.3.2. Competitive Scenario
  - 7.7.3.3. Regulatory Framework
  - 7.7.3.4. Saudi Arabia RNAi Technology Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 7.7.4. UAE
  - 7.7.4.1. Key Country Dynamics
  - 7.7.4.2. Competitive Scenario
  - 7.7.4.3. Regulatory Framework
  - 7.7.4.4. UAE RNAi Technology Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 7.7.5. Kuwait
  - 7.7.5.1. Key Country Dynamics
  - 7.7.5.2. Competitive Scenario
  - 7.7.5.3. Regulatory Framework
  - 7.7.5.4. Kuwait RNAi Technology Market Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 8. Competitive Landscape

8.1. Participant Categorization
8.2. Strategy Mapping
8.3. Company Market Position Analysis, 2023
8.4. Participant's Overview
- 8.4.1. Thermo Fisher Scientific, Inc.
  - 8.4.1.1. Overview
  - 8.4.1.2. Financial Performance
  - 8.4.1.3. Product Benchmarking
  - 8.4.1.4. Strategic Initiatives
- 8.4.2. Merck KGaA
  - 8.4.2.1. Overview
  - 8.4.2.2. Financial Performance
  - 8.4.2.3. Product Benchmarking
  - 8.4.2.4. Strategic Initiatives
- 8.4.3. Creative Biolabs
  - 8.4.3.1. Overview
  - 8.4.3.2. Financial Performance
  - 8.4.3.3. Product Benchmarking
  - 8.4.3.4. Strategic Initiatives
- 8.4.4. GenScript
  - 8.4.4.1. Overview
  - 8.4.4.2. Financial Performance
  - 8.4.4.3. Product Benchmarking
  - 8.4.4.4. Strategic Initiatives
- 8.4.5. Revvity
  - 8.4.5.1. Overview
  - 8.4.5.2. Financial Performance
  - 8.4.5.3. Product Benchmarking
  - 8.4.5.4. Strategic Initiatives
- 8.4.6. Promega Corporation
  - 8.4.6.1. Overview
  - 8.4.6.2. Financial Performance
  - 8.4.6.3. Product Benchmarking
  - 8.4.6.4. Strategic Initiatives
- 8.4.7. OriGene Technologies, Inc.
  - 8.4.7.1. Overview
  - 8.4.7.2. Financial Performance
  - 8.4.7.3. Product Benchmarking
  - 8.4.7.4. Strategic Initiatives
- 8.4.8. Altogen Biosystems
  - 8.4.8.1. Overview
  - 8.4.8.2. Financial Performance
  - 8.4.8.3. Product Benchmarking
  - 8.4.8.4. Strategic Initiatives
- 8.4.9. Danaher
  - 8.4.9.1. Overview
  - 8.4.9.2. Financial Performance
  - 8.4.9.3. Product Benchmarking
  - 8.4.9.4. Strategic Initiatives
- 8.4.10. Bioneer Corporation
  - 8.4.10.1. Overview
  - 8.4.10.2. Financial Performance
  - 8.4.10.3. Product Benchmarking
  - 8.4.10.4. Strategic Initiatives

RNAi 기술 시장 규모, 점유율, 동향 분석 리포트 : 제품 및 서비스별, 용도별, 최종 용도별, 지역별, 부문별 예측(2024-2030년)

RNAi Technology Market Size, Share & Trends Analysis Report By Product & Services (Products, Services), By Application (Drug Discovery & Development, Functional Genomics), By End-use, By Region, And Segment Forecasts, 2024 - 2030

RNAi 기술 시장의 성장과 동향 :

RNAi 기술 시장 보고서 하이라이트

목차

제1장 조사 방법과 범위

제2장 주요 요약

제3장 시장 변수, 동향, 범위

제4장 RNAi 기술 시장 : 제품 및 서비스 비즈니스 분석

제5장 RNAi 기술 시장 : 용도 비즈니스 분석

제6장 RNAi 기술 시장 : 최종 용도 비즈니스 분석

제7장 RNAi 기술 시장 : 제품·서비스, 용도, 최종 용도별 지역 추정·동향 분석

제8장 경쟁 구도

제9장 애널리스트의 견해

RNAi Technology Market Growth & Trends: